These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Effectiveness of ramelteon for residual sleep disturbances (hypersomnia) in a patient with premenstrual dysphoric disorder. Yamada K Psychiatry Clin Neurosci; 2017 Feb; 71(2):147. PubMed ID: 27868343 [No Abstract] [Full Text] [Related]
53. Sleep medicine pharmacotherapeutics overview: today, tomorrow, and the future (part 2: hypersomnia, parasomnia, and movement disorders). Gulyani S; Salas RE; Gamaldo CE Chest; 2013 Jan; 143(1):242-251. PubMed ID: 23276849 [TBL] [Abstract][Full Text] [Related]
54. Clinical evaluation of oxolinic acid in treatment of acute and chronic urinary tract infections. Budhraja SN; Perianayagam WJ Indian J Med Sci; 1978; 32(11-12):119-22. PubMed ID: 756860 [No Abstract] [Full Text] [Related]
55. Oxolinic acid and diazepam: their reciprocal antagonism in rodents. Thiébot MH; Kloczko J; Chermat R; Simon P; Soubrié P Psychopharmacology (Berl); 1980 Jan; 67(1):91-5. PubMed ID: 6768084 [TBL] [Abstract][Full Text] [Related]
56. [Central nervous system side effects of different antibacterial substances]. Stoppe G; Rüther E Infection; 1991; 19 Suppl 1():S29-32. PubMed ID: 2007512 [TBL] [Abstract][Full Text] [Related]
57. [Treatment of a hallucinatory state with diurnal hypersomnia using oxolinic acid]. Lhermitte F; Signoret JL; Agid Y; Laffont F; Jouvent R Nouv Presse Med; 1978 Dec; 7(43):3936. PubMed ID: 569844 [No Abstract] [Full Text] [Related]